Get in touch
Question, correction, peptide submission, or press inquiry — everything below routes to a real person who reads it.
Editorial & corrections
BigPeptideList is published by Simon Stern. The site is informational and independent — we accept no payment for inclusion of any peptide, no affiliate revenue from clinical-content pages, and no sponsorship from peptide retailers or compounding pharmacies. If you spot an inaccurate dosing claim, an out-of-date regulatory status, or a missing source citation, we want to know.
Email is the fastest channel. Replies usually arrive within two business days. For time-sensitive regulatory updates (FDA / Health Canada notices, schedule changes, recalls), include the source link in your message and we'll prioritize it.
simon@apricotstudios.caSubmit a peptide
Recommend a peptide we should add to the database. Include the peptide name, primary mechanism, and a primary clinical or regulatory source if you have one.
Email a submission →Press & media
Interview requests, embargoed previews, and links to coverage that cite the database. Include outlet and deadline.
Email press →Research & data
Academics, clinicians, and product teams: ask about dataset access, citation guidelines, or methodology behind the evidence tiers.
Email research →Medical questions
We can't provide medical advice. For questions about your own use of a peptide, please consult a licensed prescriber. See our disclaimer.
Email general →Editorial standards, sources, and the team behind the site are documented on the about page.